Colonisation Factor CD0873, an Attractive Oral Vaccine Candidate against Clostridioides difficile
Open Access
- 2 February 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (2), 306
- https://doi.org/10.3390/microorganisms9020306
Abstract
Clostridioides difficile is the main cause of health-care-associated infectious diarrhoea. Toxins, TcdA and TcdB, secreted by this bacterium damage colonic epithelial cells and in severe cases this culminates in pseudomembranous colitis, toxic megacolon and death. Vaccines in human trials have focused exclusively on the parenteral administration of toxin-based formulations. These vaccines promote toxin-neutralising serum antibodies but fail to confer protection from infection in the gut. An effective route to immunise against gut pathogens and stimulate a protective mucosal antibody response (secretory immunoglobulin A, IgA) at the infection site is the oral route. Additionally, oral immunisation generates systemic antibodies (IgG). Using this route, two different antigens were tested in the hamster model: The colonisation factor CD0873 and a TcdB fragment. Animals immunised with CD0873 generated a significantly higher titre of sIgA in intestinal fluid and IgG in serum compared to naive animals, which significantly inhibited the adherence of C. difficile to Caco-2 cells. Following challenge with a hypervirulent isolate, the CD0873-immunised group showed a mean increase of 80% in time to experimental endpoint compared to naïve animals. Survival and body condition correlated with bacterial clearance and reduced pathology in the cecum. Our findings advocate CD0873 as a promising oral vaccine candidate against C. difficile.Keywords
Funding Information
- Medical Research Council (CCF15-6840)
This publication has 87 references indexed in Scilit:
- Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamstersJournal of Medical Microbiology, 2013
- Proteomic Analysis and Label-Free Quantification of the Large Clostridium difficile ToxinsInternational Journal of Proteomics, 2013
- Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic ExposurePLOS ONE, 2013
- A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile InfectionInfection and Immunity, 2012
- Models for the study of Clostridium difficile infectionGut Microbes, 2012
- The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based StudyThe American Journal of Gastroenterology, 2012
- Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and BInfection and Immunity, 2011
- Murine Model ofClostridium difficileInfection with Aged Gnotobiotic C57BL/6 Mice and a BI/NAP1 StrainThe Journal of Infectious Diseases, 2010
- Improving bioscience research reporting: The ARRIVE guidelines for reporting animal researchJournal of Pharmacology and Pharmacotherapeutics, 2010
- Enhancing Oral Vaccine Potency by Targeting Intestinal M CellsPLoS Pathogens, 2010